Tech Company Financing Transactions
Histogen Funding Round
On 12/1/2010, Histogen received $10 million in Series A funding from Secure Medical and private investors.
Transaction Overview
Company Name
Announced On
12/1/2010
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
Histogen has recently moved into a new facility that will allow for up-scaled manufacturing for its upcoming clinical trials, and later commercial production.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10655 Sorrento Valley Rd.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Histogen is a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Controller
Stephen Hill
Founder
Gail Naughton
VP - Operations
Martin Latterich
VP - R & D
Michael Zimber
VP - Regulatory Affairs
Mark Hubka
Browse more venture capital transactions:
Prev: 12/1/2010: Envista venture capital transaction
Next: 12/1/2010: Adimab venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs